目的 探討Ｃ反應蛋白(CRP)在慢性阻塞性肺疾病急性加重期(AECOPD)患者治療前、后的變化和臨床意義。方法 納入2008年1月-9月住院治療的80例AECOPD患者，分別測定應用抗生素治療前后CRP、白細胞計數(WBC)、中性粒細胞百分比(N%)、血沉和體溫，并比較這些指標的變化情況。結果 AECOPD患者在感染期CRP總陽性率為100.00%，顯著高于治療前WBC、N%、血沉和體溫的陽性率(Plt;0.05)；也顯著高于感染控制后(Plt;0.05)。 結論 CRP作為細菌性感染的敏感指標之一，也可作為指導臨床及時、正確使用或評價抗生素療效的一個指標。
【摘要】 目的 分析護理干預對纖維支氣管鏡檢查患者的心理影響。方法 2008年1月—12月，通過對100例患者的問卷調查及臨床觀察,總結分析其心理特點及所采取的護理干預措施的影響。結果 纖維支氣管鏡檢查患者的心理特點有:恐懼心理、緊張心理、消極心理等；相應的護理干預:教育性干預、行為訓練、情感支持、藥物干預等。結論 正確評估患者的心理特點,采取有效的護理干預,改善患者的心理狀況,有利于提高患者的依從性,從而提高檢查的成功率。【摘要】 目的 分析護理干預對纖維支氣管鏡檢查患者的心理影響。方法 2008年1月—12月，通過對100例患者的問卷調查及臨床觀察,總結分析其心理特點及所采取的護理干預措施的影響。結果 纖維支氣管鏡檢查患者的心理特點有:恐懼心理、緊張心理、消極心理等；相應的護理干預:教育性干預、行為訓練、情感支持、藥物干預等。結論 正確評估患者的心理特點,采取有效的護理干預,改善患者的心理狀況,有利于提高患者的依從性,從而提高檢查的成功率。
ObjectiveTo explore the application of tracking method in intravenous treatment in primary hospitals, in order to improve the quality of nursing of intravenous therapy. MethodsFor the 22 events of venous transfusion adverse reactions between January and March 2013, we used tracking methodology for tracking and analyzing the reasons. Through this, we regulated and implemented specific improvement scheme, perfected rules and regulations to improve the work process. ResultsThrough reason analysis and improving regulations, the number of intravenous infusion adverse reactions was decreased from 22 in the first quarter to 0 in the fourth quarter of the year. ConclusionTracking methodology used for regulating the intravenous treatment behaviors of basic-level hospitals nurses can reduce the occurrence of adverse transfusion reaction
Objective To investigate perindopiI influence for the complication in hypertensive patients with stroke history by lowering blood pressure. Methods One-hundred and fifty-five essential hypertensive patients with stroke history were randomly assigned to either perindopril group or placebo group, receiving a randomized, double-blind, placebo-controlled trial as long as 3 years. Their blood pressure, the morbidity and mortality of cardiocerebral complications were monitored. At the end of trial, three days Ambulatory Blood Pressure Monitoring were performed. Result It was shown that in perindopril group blood pressure was controlled satisfactorily, and the morbidity and mortality of cardiocerebral incidences (6.85 % and 2.74 %repectively) were lower than those of placebo group (17.10% and 9.21% respectively). Conclusions Perindopril lowers blood pressure effectively and persistently. It has important clinical effect for prevention the cardiocerebral complications in hypertensive patients with stroke history by lowering blood pressure.